Monon Bioventures
Monon Bioventures: Transforming research into valuable assets for investors and corporate partners.
Founded
2015Monon Bioventures: Transforming research into valuable assets for investors and corporate partners.
Founded to assist world-class investigators in translating their research into clinical applications, Monon Bioventures (MBV) is a privately held company with a core mission to transform innovative ideas into valuable assets. MBV focuses on providing the necessary support to overcome early-stage challenges, ensuring that groundbreaking research can attract follow-on capital from angel investors, venture capitalists, and strategic corporate partners. Their market focus lies in bridging the gap between scientific discovery and practical, marketable solutions in the healthcare sector.
Notable affiliated individuals and investors include leading scientists and experienced venture capitalists who bring a wealth of expertise to the table. Key achievements of Monon Bioventures include successfully guiding several research projects through early development stages and securing significant investments for their commercialization. The overall impact of MBV is seen in its ability to accelerate the transition of innovative healthcare solutions from the lab to the clinic, thereby improving lives through advanced medical technologies.
Companies similar to Monon Bioventures include Bioventure Partners, Ventura BioMed Investors, Orchid BioVentures and Venture Incite.
Monon Bioventures was founded in 2015.
Monon Bioventures' headquarters is located in Fishers, IN, US.
Monon Bioventures' most recent funding round was for $398.3k (USD) in September 2022.
As of Sep 22, 2022, Monon Bioventures has disclosed funding of $398.3k (USD). Undisclosed round amounts are excluded.
Monon Bioventures has 2 employees as of Feb 4, 2024.
Venture Incite
